⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001746282

Calias Pericles

Reports to the SEC for 1 company · BALTIMORE, MD

Transactions

7

Companies

1

Filings

6

CIK

0001746282

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-12-10	AVTXAvalo Therapeutics, Inc.P Purchase	Chief Scientific Officer	PPurchase	+2,913 sh	$2.85	+$8,294.768	52,462
2019-07-16	AVTXAvalo Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,246 sh	$4.90	−$15.9K	49,216
2019-06-10	AVTXAvalo Therapeutics, Inc.P Purchase	Chief Scientific Officer	PPurchase	+4,549 sh	$2.85	+$13K	49,549
2019-05-24	AVTXAvalo Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+45K sh	—	—	45,000
2019-05-24	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2019-04-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2018-07-16	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000

Recent filings

6

Accepted (ET)
Apr 174
Calias Pericles0001578563-20-000019
SEC(opens sec.gov)
Dec 114
Calias Pericles0001578563-19-000037
SEC(opens sec.gov)
Jun 114
Calias Pericles0001578563-19-000020
SEC(opens sec.gov)
May 294
Calias Pericles0001578563-19-000018
SEC(opens sec.gov)
Apr 24
Calias Pericles0001578563-19-000010
SEC(opens sec.gov)
Jul 164
Calias Pericles0001746282-18-000003
SEC(opens sec.gov)

Companies

1

Avalo Therapeutics, Inc.Chief Scientific OfficerAVTX

Address

C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606

BALTIMORE, MD, 21202